KO Q1 2026 Earnings EPS Beats Estimates by 29 Amid Solid Operational Performance CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses MMI Q1 2026 Earnings Narrow EPS Miss Amid Quiet Revenue Reporting Shares Edge Higher XOMA Q1 2026 Earnings Royalty Revenue Challenges Lead to EPS Miss Stock Slips SENS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges PFXNZ Q1 2026 Earnings EPS Surges Past Estimates by 254 Amid Strong Portfolio Performance